[144] CompoSecure, Inc. SEC Filing

Rhea-AI Filing Summary

CompoSecure, Inc. reports a proposed sale under Rule 144 of 85,365 shares of Class A common stock, with an aggregate market value of $1,623,274.14. The shares were acquired on 01/01/2025 through the vesting of a restricted stock unit award granted under the issuers equity compensation plan. The planned disposition will be executed through Merrill Lynch on NASDAQ with an approximate sale date listed as 08/13/2025.

The filing states there were no securities sold by the filer in the past three months and includes the filers representation that they are not aware of any undisclosed material adverse information about the issuer. The notice also references Rule 10b5-1 trading plans but does not indicate that a plan was adopted.

Positive

• Shares were acquired via vesting of restricted stock units under the issuer's equity compensation plan, indicating compensation-related origin of the holdings
• No securities were reported sold in the past three months by the filer ("Nothing to Report")

Negative

• The filer proposes to sell 85,365 Class A common shares with an aggregate market value of $1,623,274.14
• The sale is scheduled to be executed through Merrill Lynch on NASDAQ with an approximate sale date of 08/13/2025

Insights

Securities Analyst

TL;DR: Proposed sale is clearly disclosed and numerically small versus total outstanding shares, so market impact appears limited.

The Form 144 shows a proposed sale of 85,365 shares versus 102,378,638 shares outstanding, reported at an aggregate market value of $1,623,274.14. These figures indicate the filer is liquidating vested RSUs rather than disposing of previously purchased stock, and the transaction will use an institutional broker on NASDAQ. From a trading-impact perspective, the disclosed quantity is modest in absolute terms; investors should view this as a routine insider sale rather than a company-level event based solely on the information provided.

Corporate Governance / Compliance Specialist

TL;DR: Disclosure follows Rule 144 format; broker-assisted sale and filers representation on material information are standard compliance elements.

The notice records acquisition by vesting of RSUs and specifies broker execution through Merrill Lynch. The filer affirms they do not possess undisclosed material adverse information and references Rule 10b5-1 plan language, though no adoption date is listed. Procedurally, the filing contains the expected compliance statements and shows Nothing to Report for prior three-month sales. On governance grounds, this appears to be a routine insider disposition with required certifications intact.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	Merrill Lynch 225 Liberty St Floor 37 New York NY 10281	85365	1623274.14	102378638	08/13/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	01/01/2025	Vesting of restricted stock unit award	CompoSecure, Inc.			85365	01/01/2025	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CompoSecure (CMPO) Form 144 disclose?

The Form 144 discloses a proposed sale of 85,365 Class A common shares, acquired via RSU vesting, with aggregate market value of $1,623,274.14.

How were the securities acquired according to the CMPO filing?

The securities were acquired on 01/01/2025 by vesting of restricted stock unit awards granted as part of the issuer's equity compensation plan.

Through which broker and exchange will the CMPO shares be sold?

Execution is planned through Merrill Lynch on NASDAQ with an approximate sale date listed as 08/13/2025.

Has the filer sold other CompoSecure shares recently?

No. The filing states "Nothing to Report" for securities sold during the past three months by the filer.

Does the filing state the filer has any undisclosed material information?

The filer represents they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.